Drug Profile
SPR 210
Alternative Names: SP 1481Latest Information Update: 15 Dec 1994
Price :
$50
*
At a glance
- Originator Sapporo Breweries
- Class Antihyperglycaemics
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic complications
Most Recent Events
- 15 Dec 1994 Discontinued-Preclinical for Diabetic complications in Japan (Unknown route)